Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Saved in:
| Title: | Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. |
|---|---|
| Authors: | Koole S; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Stein R; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Sikorska K; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands., Barton D; Department of Gynaecological Oncology, Royal Marsden Hospital NHS Trust, London, UK., Perrin L; Queensland Centre for Gynaecological Cancer, Herston, Queensland, Australia., Brennan D; Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland., Zivanovic O; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mosgaard BJ; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark., Fagotti A; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Colombo PE; Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France., Sonke G; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Driel WJV; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands w.v.driel@nki.nl.; Center for Gynaecologic Oncology Amsterdam, Center for Gynaecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Dutch Gynecological Oncology Group (DGOG), the Netherlands, the Netherlands.; Dutch Peritoneal Oncology Group (DPOG), the Netherlands, the Netherlands. |
| Corporate Authors: | OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group |
| Source: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Jun; Vol. 30 (6), pp. 888-892. Date of Electronic Publication: 2020 Mar 23. |
| Publication Type: | Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32205449 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Koole+S%22">Koole S</searchLink>; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Stein+R%22">van Stein R</searchLink>; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sikorska+K%22">Sikorska K</searchLink>; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Barton+D%22">Barton D</searchLink>; Department of Gynaecological Oncology, Royal Marsden Hospital NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Perrin+L%22">Perrin L</searchLink>; Queensland Centre for Gynaecological Cancer, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Brennan+D%22">Brennan D</searchLink>; Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Zivanovic+O%22">Zivanovic O</searchLink>; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mosgaard+BJ%22">Mosgaard BJ</searchLink>; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Fagotti+A%22">Fagotti A</searchLink>; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Colombo+PE%22">Colombo PE</searchLink>; Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sonke+G%22">Sonke G</searchLink>; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Driel+WJV%22">Driel WJV</searchLink>; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands w.v.driel@nki.nl.; Center for Gynaecologic Oncology Amsterdam, Center for Gynaecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Dutch Gynecological Oncology Group (DGOG), the Netherlands, the Netherlands.; Dutch Peritoneal Oncology Group (DPOG), the Netherlands, the Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22OVHIPEC-2+Steering+Committee+and+the+Dutch+OVHIPEC+group%22">OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229111626%22">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</searchLink> [Int J Gynecol Cancer] 2020 Jun; Vol. 30 (6), pp. 888-892. <i>Date of Electronic Publication: </i>2020 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9111626 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-1438 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221048891X%22">1048891X </searchLink><i>NLM ISO Abbreviation: </i>Int J Gynecol Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32205449 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/ijgc-2020-001231 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 888 Titles: – TitleFull: Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Koole S – PersonEntity: Name: NameFull: van Stein R – PersonEntity: Name: NameFull: Sikorska K – PersonEntity: Name: NameFull: Barton D – PersonEntity: Name: NameFull: Perrin L – PersonEntity: Name: NameFull: Brennan D – PersonEntity: Name: NameFull: Zivanovic O – PersonEntity: Name: NameFull: Mosgaard BJ – PersonEntity: Name: NameFull: Fagotti A – PersonEntity: Name: NameFull: Colombo PE – PersonEntity: Name: NameFull: Sonke G – PersonEntity: Name: NameFull: Driel WJV IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2020 Jun Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1525-1438 Numbering: – Type: volume Value: 30 – Type: issue Value: 6 Titles: – TitleFull: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Type: main |
| ResultId | 1 |